Strangles is caused by the bacterium Streptococcus equi subspecies equi (SEE) and affects horses, ponies and donkeys of all ages, although younger animals often develop more severe disease. The infection spreads readily through direct contact between horses and indirectly via contaminated clothing, tack, buckets and other equipment. Effective biosecurity and rapid identification of infected horses are therefore key to limiting transmission.
Current blood tests detect antibodies produced against a bacterial protein called SeM. While these tests are widely used, they are not always reliable. One reason is that the closely related bacterium Streptococcus equi subspecies zooepidemicus(SEZ), a common inhabitant of the equine upper respiratory tract that does not cause strangles, carries a similar SeM protein. Horses exposed to SEZ may therefore produce antibodies that generate false-positive test results. Conversely, naturally occurring changes in the SeM protein of some SEE strains may reduce the test's ability to identify infected horses.
Researchers at Texas A&M University, led by Dr Noah Cohen, have now identified a new protein that appears to overcome many of these limitations.
The team set out to identify proteins unique to the strangles bacterium that could provide a more specific target for diagnostic testing. They first cloned and produced 89 proteins found on the surface of, or secreted by, SEE.
The team then worked with Dr Philip Felgner’s laboratory at the University of California, Irvine, which used the candidate proteins to build a microarray. This tool acts as a high-throughput screening platform, allowing researchers to test dozens of potential diagnostic targets at once.
Serum samples from horses with confirmed strangles, healthy horses and horses infected with SEZ were screened to determine which proteins produced the clearest antibody responses.
One protein, designated P92, consistently distinguished horses with strangles from both healthy horses and those infected with SEZ.
The researchers then developed an ELISA blood test based on antibodies against P92 and evaluated it using serum samples from more than 230 horses collected across the United States. The new test showed significantly greater diagnostic accuracy than the conventional SeM-based assay. The area under the receiver operating characteristic curve, a standard measure of diagnostic performance, was 95% for the P92 test compared with 88% for the SeM test.
Improved diagnostic accuracy could have important practical benefits. More reliable identification of infected horses would help veterinarians make better decisions during disease investigations, allowing affected horses to be isolated promptly while reducing unnecessary restrictions resulting from false-positive results.
The discovery may also pave the way for rapid stall-side testing. Researchers are collaborating with Southwest Veterinary Diagnostics to develop a lateral-flow test, similar in principle to a home COVID-19 test, that would detect the P92 protein itself rather than antibodies against it. Detecting the bacterial protein directly could allow veterinarians to identify infected horses quickly at the point of care.
P92 may have applications beyond diagnosis. Cohen and colleagues are also investigating whether the protein could form part of a future mRNA-based strangles vaccine, potentially contributing to improved disease prevention.
Although further evaluation is needed before these new tests become widely available, the identification of P92 represents a promising advance. Better diagnostic tools could strengthen biosecurity measures, improve outbreak control and help reduce the impact of strangles on horses and equine businesses.
For more details, see:
Noah D. Cohen, Rie Nakajima, Ellen Ruth Alexander Morris, Rafael Ramiro de Assis, Emma V. Hughes, Danielle M. Gonzales, Reagan M. Baker, Rafaela L. Klein, Wen Liu, Angela I. Bordin, Philip L. Felgner.
A new single-antigen serological test accurately detects horses infected with Streptococcus equi subsp equi.
Journal of the American Veterinary Medical Association (2026).vol 264, (11) 1474

No comments:
Post a Comment